MedPath

Kontigo Care AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:5

Trial Phases

1 Phases

Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (100.0%)

A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication

Not Applicable
Completed
Conditions
Substance Use Disorder (SUD)
First Posted Date
2024-10-08
Last Posted Date
2025-04-02
Lead Sponsor
Kontigo Care AB
Target Recruit Count
34
Registration Number
NCT06629740
Locations
🇳🇱

Leiden University Medical Center (LUMC), Leiden, Netherlands

An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD

Not Applicable
Completed
Conditions
Drug Abuse
First Posted Date
2023-02-21
Last Posted Date
2024-10-07
Lead Sponsor
Kontigo Care AB
Target Recruit Count
24
Registration Number
NCT05737550
Locations
🇸🇪

Mottagning för särskild vård, sprutbytet, Husläkarmottagning för hemlösa, Uppsala, Uppland, Sweden

A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication

Not Applicable
Completed
Conditions
Drug Abuse
First Posted Date
2023-02-16
Last Posted Date
2025-04-02
Lead Sponsor
Kontigo Care AB
Target Recruit Count
48
Registration Number
NCT05731999
Locations
🇳🇱

Leiden University Medical Center (LUMC) Department of Anesthesiology, Leiden, Netherlands

Clinical Study of TripleA for Treatment of Alcohol Addiction in Outpatient Care

Not Applicable
Completed
Conditions
Alcoholism
First Posted Date
2017-06-22
Last Posted Date
2021-12-13
Lead Sponsor
Kontigo Care AB
Target Recruit Count
115
Registration Number
NCT03195894

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.